8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Cancer & Tumors54,976 citations

a risk factor in Iran, Asian Pac J Cancer Prev

Bioeffects Seen

Authors not listed · 2007

Share:

Global cancer surveillance fails to track EMF exposure despite wireless technology's rapid expansion worldwide.

Plain English Summary

Summary written for general audiences

This 2007 global cancer analysis examined worldwide cancer patterns, finding that 56% of new cases and 64% of deaths occurred in developing countries. The study revealed breast cancer as the leading cause of female cancer deaths globally, while lung cancer dominated male cancer mortality at 23% of deaths.

Why This Matters

While this study focuses on traditional cancer risk factors like smoking, it highlights a critical gap in global cancer surveillance - the absence of EMF exposure assessment. The science demonstrates that EMF sources, from cell towers to wireless devices, have proliferated dramatically since 2008, yet cancer registries still don't track EMF exposure patterns. What this means for you: as wireless technology adoption accelerates in developing countries, we're conducting an uncontrolled experiment on billions of people without proper monitoring systems in place.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2007). a risk factor in Iran, Asian Pac J Cancer Prev.
Show BibTeX
@article{a_risk_factor_in_iran_asian_pac_j_cancer_prev_ce1441,
  author = {Unknown},
  title = {a risk factor in Iran, Asian Pac J Cancer Prev},
  year = {2007},
  doi = {10.3322/caac.20107},
  
}

Quick Questions About This Study

Cancer surveillance systems established before the wireless revolution lack protocols for measuring EMF exposure. Most registries only track traditional risk factors like smoking and occupational chemicals, missing the modern reality of ubiquitous electromagnetic field exposure from phones, towers, and WiFi networks.
Dramatically. Global mobile phone subscriptions jumped from 4 billion in 2008 to over 8 billion today. Developing countries, where 64% of cancer deaths occurred according to this study, have seen the fastest wireless infrastructure growth without corresponding health monitoring systems.
Potentially yes. These regions often have weaker safety regulations, higher-power cell towers due to sparse infrastructure, and populations with limited awareness of EMF risks. Combined with poorer healthcare access noted in this study, EMF exposure could compound existing cancer burdens.
Absolutely. With wireless technology now ubiquitous and growing research linking EMF to cancer, comprehensive cancer surveillance must evolve. Future GLOBOCAN estimates should include EMF exposure metrics alongside traditional risk factors to provide accurate global cancer burden assessments.
While this study recommended tobacco control and vaccination, it missed EMF precautions. Today's evidence-based prevention should include reducing wireless device use, especially for children, using wired connections when possible, and supporting stronger EMF safety standards in developing wireless markets.